Keywords: strong, performance, glaxo, zantac, uk, pharmaceutical, company
STRONG PERFORMANCE FROM GLAXO, AND ZANTAC
Article | 13 September 1993
UK pharmaceutical company Glaxo has reported pretax profit of L 1.68 billion ($2.25 billion) for the year ended June 30, 1993, an increase of 17% ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- New study shows UCB's Neupro reduces NSBP in RLS patient
